Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-07-01T06:57:39.327Z Has data issue: false hasContentIssue false
  • English
  • Français

DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?

Published online by Cambridge University Press:  23 September 2014

Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 40 , Issue 3 , May 2013 , pp. 276 - 277
Copyright
Copyright © The Canadian Journal of Neurological 2013

References

1. Freedman, MS, Selchen, D, Arnold, DL, et al. Treatment optimization in MS: Canadian MS Working Group updated recommendations. Can J Neurol Sci. 2013;40(3):307–23.Google Scholar
2. Solomon, AJ, Klein, EP, Bourdette, D. “Undiagnosing” multiple sclerosis: the challenge of misdiagnosis in MS. Neurology. 2012; 78:1986–91.Google Scholar
3. Rolak, LA, Fleming, JO. The differential diagnosis of multiple sclerosis. Neurologist. 2007;13:57–72.Google Scholar
4. Najafi, MR, Shaygannajad, V, Mirpourian, M, Gholamrezaei, A. Vitamin B12 deficiency and multiple sclerosis; is there any association? Int J Prev Med. 2012;Apr 3(4):286–9.Google Scholar
5. Jones, JL, Dean, AF, Antoun, N, Scoffinqs, DJ, Burnet, NG, Coles, AJ. ‘Radiologically compatible CLIPPERS’ may conceal a number of pathologies. Brain. 2011;34:1–3.Google Scholar
6. Kastrup, O, Van De Nes, J, Gasser, T, Keyvani, K. Three cases of CLIPPERS: a serial clinical, laboratory and MRI follow-up study. J Neurol. 2011;258:2140–6.Google Scholar
7. Scolding, N. The differential diagnosis of MS. J Neurol Neurosurg Psychiatry. 2001;71 Suppl II:ii9–ii15.Google Scholar
8. Runia, TF, Hop, WCJ, de Rijke, YB, Buljevac, D, Hintzen, RQ. Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis. Neurology. 2012;79:261–6.Google Scholar